## CNC: Centene Corporation - XLV: Healthcare

### Executive Summary

No thesis match: PEG 1.56 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.50)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. CNC Stock Price Prediction 2026, 2027 & 2030: Analyst Targets & Quantum Computing Outlook**
- Source: Benzinga | 20251210T120739 | Neutral | Relevance: 98%
-  This article provides a comprehensive outlook on Centene Corp. (CNC) stock price predictions for 2026, 2027, and 2030, factoring in analyst targets, bullish and bearish cases, and investment considerations. It highlights potential impacts of Medicaid contract losses, ACA marketplace growth, and challenges in managing medical costs on the company's future profitability and stock valuation.

**2. Centene Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251211T163000 | Bullish | Relevance: 98%
-  Shares of Centene Corp. (CNC) advanced 4.63% to $40.46, outperforming the broader market. The S&P 500 Index (SPX) rose 0.21% and the Dow Jones Industrial Average (DJIA) increased by 1.34%, marking Centene's third consecutive day of gains.

**3. Centene (CNC) Stock Trades Up, Here Is Why**
- Source: Finviz | 20251211T171129 | Somewhat-Bullish | Relevance: 98%
-  Shares of health coverage company Centene (NYSE:CNC) jumped 5.8% after Baird raised its price target to $36 from $28, maintaining a Neutral rating. While the investment firm didn't issue a full buy recommendation, the outlook for their valuation improved. Additionally, the Hotchkis & Wiley Mid-Cap Value Fund noted Centene as an attractive investment, highlighting its market leadership and competitive edge.

**4. Centene Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251211T210908 | Bullish | Relevance: 98%
- Centene Corp. (CNC) saw its stock advance 4.63% to $40.46 on Thursday, outperforming the broader market. This marked the third consecutive day of gains for the company, as the S&P 500 Index also rose 0.21% and the Dow Jones Industrial Average increased by 1.34%.

**5. Centene Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251211T163000 | Bullish | Relevance: 97%
-  Centene Corp. (CNC) saw its stock rise by 4.63% to $40.46 on Thursday, outperforming the broader market. This gain contributed to the stock's third consecutive day of increases, occurring on a strong trading day where the S&P 500 Index and Dow Jones Industrial Average also saw positive movement.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | Bernstein | $45 | $36 | +25% |
| 2025-11-12 | Wells Fargo | $35 | $41 | -15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | Bernstein | main | Outperform |
| 2025-11-12 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.00M) |
| Sells | 2 ($2.58M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.6% (-2.8%)
- Blackrock Inc.: 9.2% (+0.3%)
- State Street Corpora: 4.3% (-7.7%)
- AQR Capital Manageme: 3.0% (+76.6%)
- Geode Capital Manage: 2.6% (-4.8%)

### Key Risks

1. Long-term trend broken: trading 8.1% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +4.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.56 elevated, pricing in significant growth expectations. Forward P/E 13.8x attractive for 46% earnings growth. Balance sheet: $1.1B free cash flow. Insider selling cluster ($2.6M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.9B |
| Beta | 0.48 |
| 52W Range | $25.08 - $66.81 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.56 |
| Forward P/E | 13.8 |
| Current P/E | 20.3 |
| YoY Growth | 46.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 0.4% to 4.5% (+4.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 73rd percentile. MRS_5 at 4.6% confirms short-term momentum alignment. AM_20 at 6.7% shows strong absolute momentum above own 20MA. Outperforming sector by 6.8pp, stock-specific strength. Below SMA200 (0.92x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.49% (CS: 73) | Strong |
| RSI_14 | 63.6 | Neutral |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.067x | Above |
| vs SMA50 | 1.100x | Above |
| vs SMA200 | 0.919x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $40.46
- **Stop Loss:** $37.50 (7.3% risk)
- **Target:** $43.42 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 466
- **Position Value:** $18,854.36
- **Portfolio %:** 18.85%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-03 (Est: $-1.19)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.16 | $0.50 | +404.3% |
| 2025Q2 | $0.21 | $-0.16 | -177.3% |
| 2025Q1 | $2.52 | $2.90 | +15.3% |
| 2024Q4 | $0.49 | $0.80 | +62.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*